MedPath

Recordati Netherlands B.V.

🇳🇱Netherlands
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:3
EMA:3

Drug Approvals

Siltuximab for Injection

Product Name
萨温珂
Approval Number
国药准字SJ20210032
Approval Date
Nov 30, 2021
NMPA

Siltuximab for Injection

Product Name
萨温珂
Approval Number
国药准字SJ20210031
Approval Date
Nov 30, 2021
NMPA

Dinutuximab beta Injection

Product Name
凯泽百
Approval Number
国药准字SJ20210023
Approval Date
Aug 12, 2021
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath